Concepedia

Jonathan Ko

JK

Statistics

Publications

3

Citations

97

H-Index

3

Active since

2017

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

German Cancer Research Center

Heidelberg Pharma (Germany)

Jonathan Ko is an author at Heidelberg University specializing in health sciences, oncology, and tumor biology.

Top concepts

Publications per year

2017–2020

3

Publications

3

HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells

Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig et al. · Molecular Cancer Therapeutics · 2020 · 70 citations · Full text

Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma

Jonathan Ko, Christian Breunig, Vianihuini Figueroa-Vazquez et al. · Blood · 2017 · 14 citations

HDP-101: Preclinical evaluation of a novel anti-BCMA antibody drug conjugates in multiple myeloma.

Andreas Pahl, Jonathan Ko, Christian Breunig et al. · Journal of Clinical Oncology · 2018 · 13 citations

, , +16

1–3 of 3